EG15009A - Process for preparing 4-amino-3-quinolinecarboxylic acids and esters-antisecretory;anti-ulcer compounds - Google Patents
Process for preparing 4-amino-3-quinolinecarboxylic acids and esters-antisecretory;anti-ulcer compoundsInfo
- Publication number
- EG15009A EG15009A EG80174A EG17480A EG15009A EG 15009 A EG15009 A EG 15009A EG 80174 A EG80174 A EG 80174A EG 17480 A EG17480 A EG 17480A EG 15009 A EG15009 A EG 15009A
- Authority
- EG
- Egypt
- Prior art keywords
- antisecretory
- esters
- amino
- preparing
- quinolinecarboxylic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2398179A | 1979-03-26 | 1979-03-26 | |
US06/127,153 US4343804A (en) | 1979-03-26 | 1980-03-04 | 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
EG15009A true EG15009A (en) | 1985-03-31 |
Family
ID=26697875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EG80174A EG15009A (en) | 1979-03-26 | 1980-03-25 | Process for preparing 4-amino-3-quinolinecarboxylic acids and esters-antisecretory;anti-ulcer compounds |
Country Status (31)
Country | Link |
---|---|
US (1) | US4343804A (sk) |
JP (1) | JPH02117663A (sk) |
AR (1) | AR230268A1 (sk) |
AT (1) | AT372373B (sk) |
AU (1) | AU528388B2 (sk) |
BR (1) | BR8001779A (sk) |
CA (1) | CA1147338A (sk) |
CH (1) | CH644105A5 (sk) |
DE (1) | DE3011490A1 (sk) |
DK (1) | DK156056C (sk) |
EG (1) | EG15009A (sk) |
ES (1) | ES489887A0 (sk) |
FI (1) | FI77452C (sk) |
FR (1) | FR2452485B1 (sk) |
GB (1) | GB2047244B (sk) |
GR (1) | GR68006B (sk) |
HK (1) | HK67983A (sk) |
IE (1) | IE49577B1 (sk) |
IL (1) | IL59628A (sk) |
IN (1) | IN151446B (sk) |
IT (1) | IT1133079B (sk) |
MX (1) | MX6264E (sk) |
NL (1) | NL8001752A (sk) |
NO (1) | NO153927C (sk) |
NZ (1) | NZ193252A (sk) |
PH (1) | PH16416A (sk) |
PL (1) | PL125030B1 (sk) |
PT (1) | PT71008B (sk) |
SE (1) | SE435837B (sk) |
SG (1) | SG33683G (sk) |
YU (1) | YU41702B (sk) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8610981D0 (en) * | 1986-05-06 | 1986-06-11 | Ici America Inc | Quinoline amides |
GB8621425D0 (en) * | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
GB8804448D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
GB8804446D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
GB8804443D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
GB8804444D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
GB8804447D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
GB8804445D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
US5432182A (en) * | 1989-02-23 | 1995-07-11 | Smithkline Beecham Intercredit B.V. | Compounds substituted quinoline derivatives |
CA2011086A1 (en) * | 1989-03-17 | 1990-09-17 | Karl-Heinz Geiss | 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom |
DE3917233A1 (de) * | 1989-05-26 | 1990-11-29 | Basf Ag | 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel |
GB8918265D0 (en) * | 1989-08-10 | 1989-09-20 | Smithkline Beckman Intercredit | Compounds |
US5362743A (en) * | 1993-03-09 | 1994-11-08 | Pfizer Inc. | Aminoquinoline derivatives |
IS4164A (is) * | 1993-06-11 | 1994-12-12 | Ab Astra | Efnasambönd sem hindra flæði magasýru |
US5556863A (en) * | 1993-06-11 | 1996-09-17 | Astra Aktiebolag | Compound for gastric acid secretion inhibition |
CA2167154A1 (en) * | 1993-08-10 | 1995-02-16 | Sarkis Barret Kalindjian | Gastrin and cck receptor ligands |
US5650415A (en) * | 1995-06-07 | 1997-07-22 | Sugen, Inc. | Quinoline compounds |
KR0169813B1 (ko) * | 1995-07-12 | 1999-01-15 | 김종인 | 4-아미노-3-아실나프티리딘 유도체 |
US5760041A (en) * | 1996-02-05 | 1998-06-02 | American Cyanamid Company | 4-aminoquinazoline EGFR Inhibitors |
US6875769B2 (en) * | 1996-05-23 | 2005-04-05 | Pfizer Inc. | Substituted6,6-hetero-bicyclicderivatives |
US5929080A (en) * | 1997-05-06 | 1999-07-27 | American Cyanamid Company | Method of treating polycystic kidney disease |
US6251912B1 (en) | 1997-08-01 | 2001-06-26 | American Cyanamid Company | Substituted quinazoline derivatives |
US6323209B1 (en) | 1997-11-06 | 2001-11-27 | American Cyanamid Company | Method of treating or inhibiting colonic polyps |
SI2253620T1 (sl) | 1998-09-29 | 2014-06-30 | Wyeth Holdings Llc | Substituirani 3-cianokinolini kot inhibitorji protein tirozin-kinaz |
WO2001047891A1 (fr) * | 1999-12-28 | 2001-07-05 | Eisai Co., Ltd. | Composes heterocylciques contenant des groupes de sulfamide |
US6521618B2 (en) | 2000-03-28 | 2003-02-18 | Wyeth | 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
US6576644B2 (en) * | 2000-09-06 | 2003-06-10 | Bristol-Myers Squibb Co. | Quinoline inhibitors of cGMP phosphodiesterase |
UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
NZ540612A (en) | 2003-01-14 | 2008-02-29 | Arena Pharm Inc | 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
CA2503290C (en) | 2003-03-10 | 2012-12-04 | Altana Pharma Ag | Novel process for the preparation of roflumilast |
AU2004257267B2 (en) * | 2003-07-14 | 2009-12-03 | Arena Pharmaceuticals,Inc | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
CA2601250C (en) * | 2005-03-16 | 2014-10-28 | Nycomed Gmbh | Taste masked dosage form containing roflumilast |
WO2011022216A1 (en) * | 2009-08-17 | 2011-02-24 | High Point Pharmaceuticals, Llc | Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress |
WO2011094008A1 (en) | 2010-01-27 | 2011-08-04 | Arena Pharmaceuticals, Inc. | Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
EP2619198A1 (en) | 2010-09-22 | 2013-07-31 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
EP4445956A2 (en) | 2015-01-06 | 2024-10-16 | Arena Pharmaceuticals, Inc. | Compound for use in treating conditions related to the s1p1 receptor |
WO2016209809A1 (en) | 2015-06-22 | 2016-12-29 | Arena Pharmaceuticals, Inc. | Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid(compound1) for use in sipi receptor-associated disorders |
ES2884073T3 (es) | 2016-11-11 | 2021-12-10 | Bayer Animal Health Gmbh | Nuevos derivados antihelmínticos de quinolina-3-carboxamida |
WO2018151873A1 (en) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
US20210177827A1 (en) * | 2017-10-25 | 2021-06-17 | Children`S Medical Center Corporation | Papd5 inhibitors and methods of use thereof |
BR112020022619A2 (pt) | 2018-05-09 | 2021-02-02 | Bayer Animal Health Gmbh | novos derivados de quinolina |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3470186A (en) * | 1967-06-02 | 1969-09-30 | American Cyanamid Co | Substituted 4-anilino-3-quinolinecarboxylic acids and esters |
JPS4838712A (sk) * | 1971-09-18 | 1973-06-07 |
-
1980
- 1980-03-04 US US06/127,153 patent/US4343804A/en not_active Expired - Lifetime
- 1980-03-14 IL IL59628A patent/IL59628A/xx unknown
- 1980-03-22 GR GR61513A patent/GR68006B/el unknown
- 1980-03-24 FI FI800910A patent/FI77452C/fi not_active IP Right Cessation
- 1980-03-24 FR FR8006516A patent/FR2452485B1/fr not_active Expired
- 1980-03-24 IE IE605/80A patent/IE49577B1/en unknown
- 1980-03-24 MX MX808722U patent/MX6264E/es unknown
- 1980-03-24 AT AT0156480A patent/AT372373B/de not_active IP Right Cessation
- 1980-03-25 DK DK128380A patent/DK156056C/da not_active IP Right Cessation
- 1980-03-25 DE DE19803011490 patent/DE3011490A1/de active Granted
- 1980-03-25 NO NO800858A patent/NO153927C/no unknown
- 1980-03-25 PT PT71008A patent/PT71008B/pt unknown
- 1980-03-25 PL PL1980222993A patent/PL125030B1/pl unknown
- 1980-03-25 GB GB8009991A patent/GB2047244B/en not_active Expired
- 1980-03-25 BR BR8001779A patent/BR8001779A/pt unknown
- 1980-03-25 ES ES489887A patent/ES489887A0/es active Granted
- 1980-03-25 EG EG80174A patent/EG15009A/xx active
- 1980-03-25 NL NL8001752A patent/NL8001752A/nl not_active Application Discontinuation
- 1980-03-25 IN IN345/CAL/80A patent/IN151446B/en unknown
- 1980-03-25 SE SE8002292A patent/SE435837B/sv not_active IP Right Cessation
- 1980-03-25 PH PH23804A patent/PH16416A/en unknown
- 1980-03-25 NZ NZ193252A patent/NZ193252A/en unknown
- 1980-03-25 CH CH234080A patent/CH644105A5/fr not_active IP Right Cessation
- 1980-03-26 AR AR280455A patent/AR230268A1/es active
- 1980-03-26 YU YU844/80A patent/YU41702B/xx unknown
- 1980-03-26 AU AU56848/80A patent/AU528388B2/en not_active Ceased
- 1980-03-26 CA CA000348417A patent/CA1147338A/en not_active Expired
- 1980-03-26 IT IT67465/80A patent/IT1133079B/it active
-
1983
- 1983-06-13 SG SG336/83A patent/SG33683G/en unknown
- 1983-12-15 HK HK679/83A patent/HK67983A/xx unknown
-
1989
- 1989-09-26 JP JP1250369A patent/JPH02117663A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG15009A (en) | Process for preparing 4-amino-3-quinolinecarboxylic acids and esters-antisecretory;anti-ulcer compounds | |
PT69172A (en) | Process for preparing 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds | |
GB2066245B (en) | Process for preparing hydroxyalkylaminosulphonic acids | |
GB2042531B (en) | Process for preparing d- -amino acids | |
PT70927A (en) | Process for preparing 9-aminoalkylfluorenes | |
PT71581A (en) | Process for preparing methylene-cycloamines | |
YU48279A (en) | Process for preparing insecticidic and acaricidic compounds | |
DE3061037D1 (en) | Process for preparing dimethylaminosilanes | |
GB2073736B (en) | Process for preparing pyridinyloxyphenoxy compounds and derivatives thereof | |
DE3266120D1 (en) | Process for preparing amino-arylsulphonic acids | |
DE3264098D1 (en) | Process for preparing 1-alkyl-2-chloro-5-nitro-benzene-4-sulphonic acids | |
DE3060089D1 (en) | Process for preparing 1-amino-2-phenoxy-4-hydroxy-anthraquinone | |
PH16358A (en) | Novel ergol-8-ene and ergolin compounds and process for preparing same | |
DE3260577D1 (en) | Process for preparing s-aryl-thioglycolic acids | |
PT71126A (en) | Process for preparing alkoxyalkylidenhydrazinopyridazines | |
GB2058068B (en) | Process for preparing 5-chloro-2-nitrophenol | |
HU178840B (en) | Process for preparing 6-chloro-alpha-methyl-carbazol-2-acetic acid | |
GB2023585B (en) | 1-pyrrole - and 1-pyrrolidine-carboxylic acid derivatives and process for preparing the same | |
DE3060850D1 (en) | Process for preparing naphthalenesulphochloride | |
YU182480A (en) | Process for obtaining alpha-aryl-propionic acids | |
ZA794245B (en) | N-phenethylacetamide compounds and process for preparation thereof | |
CU35107A (en) | Sulphonilureas process for preparing it and compounds thereof | |
PT71504A (en) | Process for preparing pyrenzepine | |
PT71231A (en) | Process for preparing steroid-carboxylates | |
DE3064662D1 (en) | Process for the preparation of 5-oxo-alkanoic acids |